Table 1.

Baseline demographics

CharacteristicsZoledronate, n=16Control, n=16P Value
Men, n (%)9 (56)10 (62)0.72
White, n (%)10 (62)11 (69)0.71
Age, yr43±1139±110.30
Time on dialysis, mo25 (13–48)27 (14–56)0.80
RRT
 Hemodialysis14 (88)14 (88)0.51
 Peritoneal dialysis2 (12)1 (6)
 Preemptive transplantation01 (6)
ESRD etiology0.23
 Chronic GN812
 Hypertensive nephrosclerosis30
 Diabetic nephropathy01
 Polycystic kidney disease11
 Other20
 Undetermined22
BMI, kg/m222.7±3.825.5±5.70.12
  • Continuous variables are presented as mean ± SD if normally distributed or median (interquartile range) if not normally distributed. BMI, body mass index.